Company Category: Obstructive sleep apnea

MLI Education

MLI is a provider of Interprofessional Continuing Education and has achieved Joint Accreditation with Commendation, allowing us to deliver accredited education designed to impact the practice behavior of the healthcare team, thus, improving patient outcomes. MLI provides credit for physicians, nurses, pharmacists, PAs, psychologists, social workers, dietitians, and optometrists. MLIʹs mission is to develop relevant, timely and targeted continuing education initiatives that promote problem‐solving and critical thinking.

Read More

Inspire Medical Systems, Inc.

Inspire Medical Systems offers an Obstructive Sleep Apnea treatment for those with moderate to severe OSA and unable to use CPAP. Utilizing well-established technologies from cardiac pacing and neurostimulation, Inspire developed a proprietary Upper Airway Stimulation (UAS) therapy designed to improve sleep and enrich the lives of people suffering from this challenging condition. The Inspire system is implanted during an outpatient procedure and uses mild stimulation to keep the airway open during sleep. The therapy has broad commercial and Medicare coverage, with over 1,000 clinics managing 75,000+ patients. Inspire has proven sustained results and 91% patient satisfaction.

Read More

Harvard Bioscience Inc

Solutions from Harvard Bioscience are more than instruments. With exceptional service, we are partners in the quest for knowledge and discovery. Showcasing our BUXCO and FinePointe Inhalation and Respiratory portfolio, we give researchers the confidence to conduct reliable, reproducible research, from initial exposure through pulmonary assessment. Visit our website (harvardbioscience.com) and meet us at booth #528 to explore how cutting-edge technology advances your research. From in vitro to in vivo, we have you covered.

Read More

Fisher & Paykel Healthcare Inc

Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of respiratory products and therapy solutions based on five decades of clinical research and development. New Zealand-based, our products are sold to more than 120 countries. Optiflow™ nasal high flow has been well established within critical care for over 20 years and its use in other areas is expanding. Our purpose is to improve care and outcomes through inspired and world-leading healthcare solutions.

Read More

Endo-Therapeutics, Inc.

Endo-Therapeutics, based in Clearwater, FL, is a leading medical device manufacturer with over 30 years of experience specializing in the design and development of single-use endoscopic devices. As one of the top domestic producers of biopsy forceps and polypectomy snares in the US, we are proud to deliver millions of single-use devices worldwide. We’ve recently expanded into the pulmonology market—our pulmonology products include Single-use Flexible Bronchoscopes, BioCeps Biopsy Forceps, and the EndoTBrush Cytology Brush.

Read More

Eli Lilly and Company

Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom. | Lilly unites caring with discovery to create medicines that improve lives for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today, our medicines help more than 51 million people worldwide. We’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter, and LinkedIn. | Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people.

Read More

Dormotech

Dormotech is a forward-thinking health tech company revolutionizing how sleep health is assessed and managed. Our flagship product, DormoVision X™, is a fully wireless, multi-channel sleep diagnostic platform delivering clinical-grade, PSG-equivalent data across 38 channels (29 direct), including full EEG, respiratory, cardiac, and oxygenation signals. Supporting Type I, II, and III studies on a single scalable system, it enables both self-applied home testing and live-streamed, attended in-lab monitoring. With automated scoring and an intuitive clinical dashboard, DormoVision X™ transforms complex physiologic data into actionable insight, helping sleep centers expand access, reduce re-testing, and improve operational efficiency without the infrastructure burden of traditional lab systems.

Read More